ArticleCureus2024
Adjusting for Glycemic Control in Assessing the Relationship Between Age-Related Macular Degeneration and Diabetic Retinopathy.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Association between diabetic retinopathy and age-related macular degeneration: a systematic review and meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose Studies regarding the relationship between age-related macular degeneration (AMD) and diabetic retinopathy (DR) conflict: while some support that AMD is protective against DR, others find the opposite. The mechanism by which AMD may protect against DR is unclear. We sought to assess the association between AMD and DR when controlling for glycemic control in patients with diabetes mellitus (DM) type II. Methods We identified 461 unique patients over 55 years old with a diagnosis of DM type II seen in our academic retina clinic in Stony Brook, New York between 12/31/2019 and 12/31/2020. Data were manually extracted and the population was split based on the presence of AMD diagnosis. Multivariate regression analyses were then performed comparing the prevalence of DR between groups while controlling for A1c. Secondary endpoints included demographic differences and smoking status. Results Among the 461 patients, 118 (25.6%) had a diagnosis of AMD. Compared to patients without AMD, patients with AMD were older (69 vs. 66; OR 1.05; p=0.005) and less likely to have DR (37.3% vs. 59.2%; OR 0.35; p<0.001). There was no difference in average A1c between groups. Conclusion This is the first reported study assessing the relationship between AMD and DR while controlling for A1c. In our population, diagnosis of AMD was associated with significantly reduced odds of having DR. As AMD and DR appear to be related even after holding A1c constant, researchers should use caution when using DR as a surrogate for diabetic control in the context of AMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.